Respiration

Clinical Investigations

Mortality from Occupational Exposure to Relatively Pure Chrysotile: A 39-Year Study

Sichletidis L. · Chloros D. · Spyratos D. · Haidich A.-B. · Fourkiotou I. · Kakoura M. · Patakas D.

Author affiliations

Laboratory for the Study of Environmental Diseases, Pulmonary Clinic of Aristotle University of Thessaloniki, Thessaloniki, Greece

Related Articles for ""

Respiration 2009;78:63–68

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Clinical Investigations

Received: December 31, 2007
Accepted: July 11, 2008
Published online: October 09, 2008
Issue release date: July 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES

Abstract

Background: Asbestos exposure is related to serious adverse health effects. However, there is disagreement about the relationship between chrysotile exposure and mesothelioma or lung cancer. Objectives: Our aim was to investigate the mortality rate among workers exposed to relatively pure chrysotile in an asbestos cement factory. Patients and Methods: In an asbestos cement plant opened in 1968, we prospectively studied all 317 workers. A quantity of 2,000 tons of chrysotile, with minimal amphibole contamination, was used annually until 1 January 2005. Asbestos fiber concentration was measured regularly. Date and cause of death were recorded among active and retired workers. Results: Asbestos fiber concentration was always below permissible levels. Fifty-two workers died during the study. The cause was cancer in 28 subjects; lung cancer was diagnosed in 16 of them. No case of mesothelioma was reported. Death was attributed to cardiovascular diseases in 23 subjects and to liver cirrhosis in 1. Overall mortality rate was significantly lower than that of the Greek general population, standardized mortality ratio (SMR) was 0.71 (95% CI 0.53–0.93). Mortality due to cancer was increased (SMR 1.15, 95% CI 0.77–1.67), mainly due to lung cancer mortality (SMR 1.71, 95% CI 0.98–2.78), but not significantly. Conclusions: Occupational exposure to relatively pure chrysotile within permissible levels was not associated with a significant increase in lung cancer or with mesothelioma. Decreased overall mortality of workers indicates a healthy worker effect, which – together with the relatively small cohort size – could have prevented small risks to be detected.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Browne K: Asbestos-related disorders; in Parkes WR (ed): Occupational Lung Disorders, ed 3. London, Butterworth-Heinemann, 1994, pp 411–504.
  2. Directive 2003/18/EC of the European Parliament and of the Council of 27th March 2003 amending Council Directive 83/477/EEC on the protection of workers from the risks related to exposure to asbestos at work. Off J Eur Union 2003;L 97:48–52.
  3. Dement JM, Harris RL Jr, Symons MJ, et al: Exposures and mortality among chrysotile asbestos workers. Part II. Mortality. Am J Ind Med 1983;4:421–433.
  4. Peto J, Doll R, Hermon C, Binns W, Clayton R, Goffe T: Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg 1985;29:305–355.
  5. Stayner LT, Dankovic DA, Lemen RA: Occupational exposure to chrysotile asbestos and cancer risk: a review of the amphibole hypothesis. Am J Public Health 1996;86:179–186.
  6. Yano E, Wang ZM, Wang XR, Wang MZ, Lan YJ: Cancer mortality among workers exposed to amphibole-free chrysotile. Am J Epidemiol 2001;154:538–543.
  7. Yarborough CM: Chrysotile as a cause of mesothelioma: an assessment based on epidemiology. Am Rev Toxicol 2006;36:165–187.
  8. Gardner MJ, Winter PD, Pannett B, Powell CA: Follow up study of workers manufacturing chrysotile asbestos cement products. Br J Ind Med 1986;43:726–732.
  9. Neuberger M, Kundi M: Individual asbestos exposure: smoking and mortality – a cohort study in the asbestos cement industry. Br J Ind Med 1990;47:615–620.
  10. McDonald JC, McDonald AD: Chrysotile, tremolite and carcinogenicity. Ann Occup Hyg 1997;41:699–705.
  11. Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT: Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases. Ultrastruct Pathol 2002;26:55–65.
  12. Yarborough CM: The risk of mesothelioma from exposure to chrysotile asbestos. Curr Opin Pulm Med 2007;13:334–338.
  13. Huuskonen MS, Karjalainen A, Tossavainen A, et al: Asbestos and cancer in Finland. Med Lav 1995;86:426–434.
  14. Council Directive 83/477/EEC of 19 September 1983 on the protection of workers from the risks related to exposure to asbestos at work (second individual directive within the meaning of article 8 of directive 80/1107/EEC). Off J Eur Union 1983;L 263:25–32.
  15. Breslow NE, Day NE: Statistical Methods in Cancer Research. IARC Scientific Publication No. 82. Lyon, International Agency for Research on Cancer, 1987, vol 2: The Design and Analysis of Cohort Studies.
  16. Collett D: Modelling Survival Data in Medical Research. Boca Raton, Chapman & Hall, 1993.
  17. Sichletidis L, Chloros D, Tsiotsios I, et al: High prevalence of smoking in Northern Greece. Primary Care Respir J 2006;15:92–97.
  18. Dement JM, Brown DP, Okun A: Follow-up study of chrysotile textile workers: cohort mortality and case-control analyses. Am J Ind Med 1994;26:431–447.
  19. Raffn E, Lynge E, Juel K, Korsgaard B: Incidence of cancer and mortality among employees in the asbestos-cement industry in Denmark. Br J Ind Med 1989;46:90–96.
  20. Hughes JM, Weill H: Asbestos exposure: quantitative assessment of risk. Am Rev Respir Dis 1986;133:5–13.
  21. McDonald JC, McDonald AD: The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9:1932–1942.
  22. Newhouse ML, Sullivan KR: A mortality study of workers manufacturing friction materials 1941–1986. Br J Ind Med 1989;46:176–179.
  23. Hodgson JT, Darnton A: The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565–601.
  24. Bernstein DM, Hoskins JA: The health effects of chrysotile: current perspective based upon recent data. Regul Toxicol Pharmacol 2006;45:252–264.
  25. Bernstein DM: Asbestos; in Salem H, Katz SA (eds): Inhalation Toxicology, ed 2. New York, Taylor and Francis Group, 2006, pp 647–667.
  26. Hughes JM, Weill H, Hammad YY: Mortality of workers employed in two asbestos cement manufacturing plants. Br J Ind Med 1987;44:161–174.
  27. Hesterberg TW, Hart GA: Synthetic vitreous fibers: a review of toxicology research and its impact on hazard classification. Crit Rev Toxicol 2001;31:1–53.
  28. Topinka J, Loli P, Dusinska M, et al: Mutagenesis by man-made mineral fibers in the lung of rats. Mutat Res 2006;595:174–183.

Article / Publication Details

First-Page Preview
Abstract of Clinical Investigations

Received: December 31, 2007
Accepted: July 11, 2008
Published online: October 09, 2008
Issue release date: July 2009

Number of Print Pages: 6
Number of Figures: 0
Number of Tables: 3

ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)

For additional information: https://www.karger.com/RES


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP